Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

August 18, 2022 01:02:07
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update
MitoAction Expert Series
Reneo Pharmaceuticals LC-FAOD REN001 Clinical Trial Update

Aug 18 2022 | 01:02:07

/

Show Notes

There was much discussion about current research in FAODs at our recent International Metabolic conference last month. Reneo Pharmaceuticals recently released positive results from the REN001 Phase1b LC-FAOD Study.

Other Episodes

Episode 0

July 07, 2020 01:10:03
Episode Cover

Molecular Diagnostic Testing for Mitochondrial Disorders - Dr. Darius Adams - 10/7/2016

Dr. Darius Adams, a clinical geneticist, discusses molecular diagnostic testing for mitochondrial disorders. Dr. Adams, Medical Director of the Goryeb Children’s Hospital Genetics and...

Listen

Episode 0

June 08, 2020 01:08:50
Episode Cover

FAOD: The Other Mitochondrial Energy Diseases - Dr. Jerry Vockley - 10/4/19

About the Speaker Dr. Vockley received his undergraduate degree at Carnegie-Mellon University in Pittsburgh, Pennsylvania, and received his degree in Medicine and Genetics from...

Listen

Episode

May 19, 2022 00:55:42
Episode Cover

Immune Function and Mitochondrial Disease

What is the impact of illness or infection on a patient with mitochondrial disease? Patients, parents, and healthcare providers with firsthand experience of mitochondrial...

Listen